Dr. Hans Van der Weken studied Biochemistry and Biotechnology at Ghent University and obtained his PhD at the faculty of Veterinary Medicine. He is currently employed as a postdoctoral scientist at the laboratory of Veterinary Immunology where his research focuses on the development of an oral vaccination platform utilizing APN as a gateway through the gut barrier. His expertise spans antibody production systems, protein engineering and mucosal immunology.